Victor Musiime

Summary

Country: UK

Publications

  1. ncbi request reprint Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 19:269-76. 2014
  2. ncbi request reprint Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe
    Victor Musiime
    Joint Clinical Research Center, Kampala, Uganda
    Pediatr Infect Dis J 32:856-62. 2013
  3. ncbi request reprint Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children
    Victor Musiime
    Joint Clinical Research Centre JCRC, Kampala, Uganda
    AIDS Res Hum Retroviruses 29:449-55. 2013
  4. doi request reprint Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda
    Victor Musiime
    Joint Clinical Research Centre, Headquarters, Kampala, Uganda
    AIDS Res Hum Retroviruses 28:1647-57. 2012
  5. doi request reprint Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda
    Victor Musiime
    Joint Clinical Research Centre, Clinic, Kampala, Uganda
    J Int Assoc Physicians AIDS Care (Chic) 8:185-90. 2009
  6. ncbi request reprint Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine
    Victor Musiime
    Joint Clinical Research Centre, Butikiro House, Kampala, Uganda
    AIDS Res Hum Retroviruses 25:989-96. 2009
  7. ncbi request reprint The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands Baylor College of Medicine Children s Foundation Uganda, Mulago Hospital Kampala, Kampala, Uganda MRC Clinical Trials Unit at University College London, London, United Kingdom and Drugs for Neglected Diseases Initiative, Geneva, Switzerland
    J Acquir Immune Defic Syndr 66:148-54. 2014
  8. doi request reprint A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child
    Eva Natukunda
    Joint Clinical Research Centre, Kampala, Uganda
    AIDS Res Hum Retroviruses 27:373-6. 2011
  9. doi request reprint Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 15:1115-24. 2010

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 19:269-76. 2014
    ..We compared body circumferences, skin-fold thickness (SFT) and lipids in antiretroviral therapy (ART)-naive and stavudine (d4T)-exposed children with HIV-uninfected controls...
  2. ncbi request reprint Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and Zimbabwe
    Victor Musiime
    Joint Clinical Research Center, Kampala, Uganda
    Pediatr Infect Dis J 32:856-62. 2013
    ..Bacteremia is common in HIV-infected children in Africa, including after start of antiretroviral therapy (ART), but there are limited data on causative pathogens and their antimicrobial sensitivity patterns in this population...
  3. ncbi request reprint Antiretroviral drug resistance profiles and response to second-line therapy among HIV type 1-infected Ugandan children
    Victor Musiime
    Joint Clinical Research Centre JCRC, Kampala, Uganda
    AIDS Res Hum Retroviruses 29:449-55. 2013
    ..Multiple RAMs were observed among HIV-1-infected children with virological failure on first-line ART with M184V and K103N most frequent. The children responded favorably to boosted PI-based second-line ART...
  4. doi request reprint Response to antiretroviral therapy of HIV type 1-infected children in urban and rural settings of Uganda
    Victor Musiime
    Joint Clinical Research Centre, Headquarters, Kampala, Uganda
    AIDS Res Hum Retroviruses 28:1647-57. 2012
    ..130), and in 78.8% of urban versus 88.8% of rural children by PC (p<0.0001). In this study rural children had more favorable clinical outcomes and were more likely to adhere optimally to ART than urban children...
  5. doi request reprint Enteric bacterial pathogens in HIV-infected children with acute diarrhea in Mulago referral and teaching hospital, Kampala, Uganda
    Victor Musiime
    Joint Clinical Research Centre, Clinic, Kampala, Uganda
    J Int Assoc Physicians AIDS Care (Chic) 8:185-90. 2009
    ..HIV-infected children develop severe bacterial infections. We set out to determine the enteric bacterial pathogens in HIV-infected children and HIV-negative controls with acute diarrhea and their antimicrobial sensitivities...
  6. ncbi request reprint Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine
    Victor Musiime
    Joint Clinical Research Centre, Butikiro House, Kampala, Uganda
    AIDS Res Hum Retroviruses 25:989-96. 2009
    ....
  7. ncbi request reprint The pharmacokinetics and acceptability of lopinavir/ritonavir minitab sprinkles, tablets, and syrups in african HIV-infected children
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda Department of Pharmacy, Radboud University Medical Centre, Nijmegen, the Netherlands Baylor College of Medicine Children s Foundation Uganda, Mulago Hospital Kampala, Kampala, Uganda MRC Clinical Trials Unit at University College London, London, United Kingdom and Drugs for Neglected Diseases Initiative, Geneva, Switzerland
    J Acquir Immune Defic Syndr 66:148-54. 2014
    ..Guidelines recommend lopinavir/ritonavir (LPV/r) as first- and second-line therapy for young and older HIV-infected children, respectively. Available formulations have limitations making their widespread use complex...
  8. doi request reprint A Case of Cryptococcal Lymphadenitis in an HIV-Infected Child
    Eva Natukunda
    Joint Clinical Research Centre, Kampala, Uganda
    AIDS Res Hum Retroviruses 27:373-6. 2011
    ..Therefore cryptococcal lymphadenitis should be considered in the differential diagnosis of children presenting with lymphadenopathy and a positive serum CRAG...
  9. doi request reprint Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial
    Victor Musiime
    Joint Clinical Research Centre, Kampala, Uganda
    Antivir Ther 15:1115-24. 2010
    ..We compared the pharmacokinetics (PK) of once- versus twice-daily lamivudine and abacavir treatment using the World Health Organization recommended weight band dosing of scored adult tablets...